At the time of writing, Kestra Medical Technologies Ltd [KMTS] stock is trading at $27.2, up 4.27%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The KMTS shares have gain 8.39% over the last week, with a monthly amount glided 4.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kestra Medical Technologies Ltd [NASDAQ: KMTS] stock has seen the most recent analyst activity on November 18, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $32. Previously, Wolfe Research started tracking the stock with Outperform rating on March 31, 2025, and set its price target to $29. On March 31, 2025, Wells Fargo initiated with an Overweight rating and assigned a price target of $28 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $28 on March 31, 2025. Piper Sandler initiated its recommendation with an Overweight and recommended $27 as its price target on March 31, 2025. Goldman started tracking with a Neutral rating for this stock on March 31, 2025, and assigned it a price target of $24. In a note dated March 31, 2025, BofA Securities initiated a Buy rating and provided a target price of $30 on this stock.
For the past year, the stock price of Kestra Medical Technologies Ltd fluctuated between $13.25 and $30.00. Kestra Medical Technologies Ltd [NASDAQ: KMTS] shares were valued at $27.2 at the most recent close of the market.
Analyzing the KMTS fundamentals
According to Kestra Medical Technologies Ltd [NASDAQ:KMTS], the company’s sales were 66.40M for trailing twelve months, which represents an 51.55% jump. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -1.89%, Pretax Profit Margin comes in at -1.91%, and Net Profit Margin reading is -1.92%. To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is 2.89 and Total Capital is -0.42. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 25.85 points at the first support level, and at 24.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.45, and for the 2nd resistance point, it is at 29.70.
Ratios To Look Out For
It is important to note that Kestra Medical Technologies Ltd [NASDAQ:KMTS] has a current ratio of 6.84. Further, the Quick Ratio stands at 6.63, while the Cash Ratio is 6.24. Considering the valuation of this stock, the price to sales ratio is 21.08, the price to book ratio is 7.59.
Transactions by insiders
Recent insider trading involved COHEN RAYMOND W, Director, that happened on Mar 07 ’25 when 17000.0 shares were purchased.
